These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30217375)

  • 1. Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction.
    Choi JY; Choi CU; Hwang SY; Choi BG; Jang WY; Kim DY; Kim W; Park EJ; Lee S; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Chae SC; Kim YJ; Cho MC; Kim CJ; Kim HS; Jeong MH;
    Am J Cardiol; 2018 Sep; 122(6):922-928. PubMed ID: 30217375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins.
    Choi JY; Choi CU; Choi BG; Park Y; Kang DO; Jang WY; Kim W; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Jeong MH; Chae SC; Seong IW; Yoon CH; Cha KS; Oh SK;
    BMC Pharmacol Toxicol; 2021 Feb; 22(1):11. PubMed ID: 33541430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different diabetogenic effect of statins according to intensity and dose in patients with acute myocardial infarction: a nationwide cohort study.
    Lee J; Choi JY; Choi BG; Choi YJ; Park S; Kang DO; Park EJ; Kim JB; Roh SY; Na JO; Choi CU; Kim EJ; Park CG; Jeong MH; Hwang JY; Hur SH; Jeong JO; Oh S; Rha SW;
    Sci Rep; 2024 Aug; 14(1):19438. PubMed ID: 39169014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial.
    Hong SJ; Lee YJ; Kang WC; Hong BK; Lee JY; Lee JB; Yang TH; Yoon J; Lee SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK;
    Cardiovasc Diabetol; 2024 Aug; 23(1):287. PubMed ID: 39113067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases.
    Seo WW; Seo SI; Kim Y; Yoo JJ; Shin WG; Kim J; You SC; Park RW; Park YM; Kim KJ; Rhee SY; Park M; Jin ES; Kim SE
    Cardiovasc Diabetol; 2022 May; 21(1):82. PubMed ID: 35606846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study.
    Lin JL; Chen PS; Lin HW; Tsai LM; Lin SH; Li YH
    J Atheroscler Thromb; 2022 Aug; 29(8):1213-1225. PubMed ID: 34497171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.
    Yoon D; Sheen SS; Lee S; Choi YJ; Park RW; Lim HS
    Medicine (Baltimore); 2016 Nov; 95(46):e5429. PubMed ID: 27861386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
    Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.
    Giustino G; Colantonio LD; Brown TM; Carson AP; Dai Y; Farkouh ME; Monda KL; Muntner P; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Oct; 32(5):453-461. PubMed ID: 30078077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study.
    Liu WT; Lin C; Tsai MC; Cheng CC; Chen SJ; Liou JT; Lin WS; Cheng SM; Lin CS; Tsao TP
    Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33202854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study.
    Tarim BA; Fici F; Tengiz I; Avunduk S; Ozcan Y; Faikoglu G; Ari E; Robles NR; Grassi G
    Yonsei Med J; 2023 Mar; 64(3):175-180. PubMed ID: 36825343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain].
    Cosin Sales J; Fuentes Jiménez FJ; Mantilla Morató T; Ruiz E; Becerra V; Aceituno S; Ferrario MG; Lizán L; Gracia A
    Clin Investig Arterioscler; 2015; 27(5):228-38. PubMed ID: 25640158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes.
    Park JY; Rha SW; Choi B; Choi JW; Ryu SK; Kim S; Noh YK; Choi SY; Akkala RG; Li H; Ali J; Xu S; Ngow HA; Lee JJ; Lee GN; Kim J; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim E; Park CG; SeogSeo H; Oh DJ
    Int J Cardiol; 2015 Apr; 184():502-506. PubMed ID: 25756579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New onset diabetes mellitus and cardiovascular outcomes according to statin intensity in patients after drug-eluting stent implantation in Asian patients.
    Chung J; Kim HL; Lim WH; Seo JB; Zo JH; Kim MA; Kim SH
    Sci Rep; 2023 Sep; 13(1):16061. PubMed ID: 37749120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg.
    Stein B; Ward T; Hale G; Lyver E
    Ann Pharmacother; 2020 May; 54(5):405-413. PubMed ID: 31718234
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
    He W; Cao M; Li Z
    Drug Dev Res; 2020 Aug; 81(5):551-556. PubMed ID: 32142170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
    Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
    Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study.
    Chitose T; Sugiyama S; Sakamoto K; Shimomura H; Yamashita T; Hokamaki J; Tsunoda R; Shiraishi S; Yamashita Y; Ogawa H
    Atherosclerosis; 2014 Nov; 237(1):251-8. PubMed ID: 25262434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.
    Ji MS; Jeong MH; Ahn YK; Kim SH; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Int J Cardiol; 2016 Dec; 225():50-59. PubMed ID: 27710803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.